- Home
- ENGN vs NAUT Comparison
ENGN vs NAUT Comparison
Compare ENGN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- NAUT
- Stock Information
- Founded
- ENGN 1999
- NAUT 2016
- Country
- ENGN Canada
- NAUT United States
- Employees
- ENGN N/A
- NAUT N/A
- Industry
- ENGN
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- ENGN
- NAUT Industrials
- Exchange
- ENGN Nasdaq
- NAUT Nasdaq
- Market Cap
- ENGN 317.6M
- NAUT 284.7M
- IPO Year
- ENGN N/A
- NAUT N/A
- Fundamental
- Price
- ENGN $5.83
- NAUT $1.77
- Analyst Decision
- ENGN Strong Buy
- NAUT Hold
- Analyst Count
- ENGN 9
- NAUT 3
- Target Price
- ENGN $29.78
- NAUT $3.58
- AVG Volume (30 Days)
- ENGN 206.9K
- NAUT 180.7K
- Earning Date
- ENGN 12-19-2024
- NAUT 10-29-2024
- Dividend Yield
- ENGN N/A
- NAUT N/A
- EPS Growth
- ENGN N/A
- NAUT N/A
- EPS
- ENGN N/A
- NAUT N/A
- Revenue
- ENGN N/A
- NAUT N/A
- Revenue This Year
- ENGN N/A
- NAUT N/A
- Revenue Next Year
- ENGN N/A
- NAUT N/A
- P/E Ratio
- ENGN N/A
- NAUT N/A
- Revenue Growth
- ENGN N/A
- NAUT N/A
- 52 Week Low
- ENGN $4.42
- NAUT $1.65
- 52 Week High
- ENGN $18.40
- NAUT $3.46
- Technical
- Relative Strength Index (RSI)
- ENGN 36.65
- NAUT 30.18
- Support Level
- ENGN $5.60
- NAUT $1.65
- Resistance Level
- ENGN $6.54
- NAUT $2.10
- Average True Range (ATR)
- ENGN 0.66
- NAUT 0.14
- MACD
- ENGN -0.10
- NAUT -0.02
- Stochastic Oscillator
- ENGN 23.28
- NAUT 14.29
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.